...
首页> 外文期刊>American Biotechnology Laboratory >A versatile encapsulation technolgoy
【24h】

A versatile encapsulation technolgoy

机译:通用的封装技术

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, interest in liposome vesicular structures has increased as a result of their potential use as delivery systems for drugs and other bioactive materials. The first liposome technology centered on vesicles composed of phospholipids, generally phosphatidylcholine, and work continues with this class of compounds. However, there are some disadvantages: First, the compounds tend to be unstable, and manufactured products using phospholipids have low shelf life; second, they are expensive to purify and synthesize. Therefore, there has been keen interest in finding other compounds to replace phospholipid liposomes that can function as membrane mimetic amphiphiles. Such compounds have "heads" that are hydrophilic and "tails" that are hydrophobic. Typical amphiphiles are long-chain fatty acids and their derivatives, long-chain alcohols and their derivatives, long-chain amines and amides, polyolipids, and sphingo- and glycerolipids. Liposomes of this type do not have the disadvantages given above for phospholipids. Some of their properties and applications are described here, specifically pertaining to the patented Novasome~R lipid vesicle technology (IGI, Inc., Buena, NJ).
机译:近年来,由于脂质体囊泡结构潜在地用作药物和其他生物活性物质的递送系统,因此对脂质体囊泡结构的兴趣增加了。第一个脂质体技术集中在由磷脂(通常是磷脂酰胆碱)组成的囊泡上,并且继续研究这类化合物。但是,存在一些缺点:首先,这些化合物趋于不稳定,并且使用磷脂制成的产品的货架期很短;其次,它们的纯化和合成非常昂贵。因此,人们对寻找其他化合物来代替能够充当膜模拟两亲物的磷脂脂质体有着浓厚的兴趣。这样的化合物具有亲水的“头部”和疏水的“尾部”。典型的两亲物是长链脂肪酸及其衍生物,长链醇及其衍生物,长链胺和酰胺,聚烯烃脂以及鞘脂和甘油脂。这种类型的脂质体不具有上述磷脂的缺点。本文描述了它们的一些特性和应用,特别是与专利的Novasome®R脂质囊泡技术(IGI,Inc.,Buena,NJ)有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号